September 24, 2024 11:45 ET | Source: Transgene S.A. Transgene S.A.
Rapport Semestriel 2024
Pièce jointe
Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of June 30, 2026
Transgene to Present Preclinical Data Demonstrating Robust Protection Against Mpox with its Novel Scalable Cell Line–Derived MVA Vaccine Candidate at WCID